Novel urine-based prognostic model promises to transform bladder cancer treatment

The still-mysterious immunologic syndrome known as VEXAS seems to include heightened risk of infection, said researchers who warned that their findings suggest that the condition

Pfiz­er said Tues­day that US and Eu­ro­pean reg­u­la­tors have ac­cept­ed its fil­ings seek­ing ap­proval for a gene ther­a­py that re­duces bleed rates in he­mo­phil­ia B